Paid Clinical Trials in Baton Rouge, LA
As of August 2026, 191 paid clinical trials are recruiting in Baton Rouge, Louisiana. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Baton Rouge offers studies at sites including Pennington Biomedical Research Center for conditions such as Obesity, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Baton Rouge
Trials by drug in Baton Rouge
Filter results
Newly added in Baton Rouge
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
178 clinical trials
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Top Research Study Locations in Baton Rouge
Researchers run research studies in Baton Rouge, LA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Pennington Biomedical Research Center | Obesity, Health Behavior, Insulin Sensitivity | 36 |
| Mary Bird Perkins Cancer Center | Chronic Lymphocytic Leukemia, Neoplasm Metastasis, Small Lymphocytic Lymphoma | 29 |
| Our Lady of the Lake Physician Group | Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy | 23 |
| LSU Health Baton Rouge-North Clinic | Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy | 22 |
| Louisiana Hematology Oncology Associates LLC | Muscle Invasive Bladder Urothelial Carcinoma, Stage IV Breast Cancer AJCC v6 and v7, Stage IV Renal Cell Cancer AJCC v8 | 14 |
| Our Lady of The Lake | Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy | 14 |
| Woman's Hospital | 22q11.2 Deletion Syndrome, Aneuploidy, Cardiotoxicity | 6 |
| Our Lady of the Lake Medical Oncology | Cardiotoxicity, Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma | 5 |
| Our Lady of the Lake Hospital | Chronic Lymphocytic Leukemia, B Cell Lymphoma, CLL | 4 |
| GI Alliance - Baton Rouge | Ulcerative Colitis, Crohn's Disease | 4 |
| Our Lady of the Lake Regional Medical Center | AAA - Abdominal Aortic Aneurysm, EGFR Exon 19 Deletion Mutation, Lung Cancer - Non Small Cell | 4 |
| DelRicht Research | Acute Gout Flare, Acute Gouty Arthritis, Common Warts | 3 |
| GSK Investigational Site | Multiple Myeloma, Pulmonary Disease, Chronic Obstructive, Systemic Lupus Erythematosus | 3 |
| Louisiana Hematology Oncology Associates | Stage IV Breast Cancer AJCC v6 and v7, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 3 |
| Medical Center of Baton Rouge | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 3 |
| Renal Associates of Baton Rouge | End Stage Kidney Disease, Focal Segmental Glomerulosclerosis, Proteinuric Kidney Disease | 3 |
| Velocity Clinical Research - Baton Rouge | Diabetic Peripheral Neuropathic Pain, Obesity, Overweight | 3 |
| Baton Rouge General Medical Center | Acute Limb Ischemia, Moderately to Severely Active Crohns Disease, Peripheral Arterial Disease | 2 |
| Louisiana State University | Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder | 2 |
| Mary Bird Perkins Cancer Ctr | B-Cell Non-Hodgkins Lymphoma, Metastatic Colorectal Cancer | 2 |
| Ochsner High Grove | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 2 |
| Our Lady of the Lake Hospital, Inc. | Acute Respiratory Failure, Extensive-stage Small-cell Lung Cancer | 2 |
| Pennington Biomed Res Ctr | Obesity, Overweight | 2 |
| Pennington Biomedical Resarch Center | Obesity | 2 |
| LSU Health Baton Rouge North Clinic | Non Small Cell Lung Cancer, Non-small Cell Lung Cancer | 2 |
Active & Upcoming Studies in Baton Rouge (2026)
Recruiting trials in Baton Rouge grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (74 active studies)
- Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS) · Phase 4 · Regeneron Pharmaceuticals
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
Diabetes & metabolic (25 active studies)
- Continuous Glucose Monitoring in Metabolic Surgery · Pennington Biomedical Research Center
- Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Neurology & pain (8 active studies)
- Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition · Pennington Biomedical Research Center
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
Cardiovascular (6 active studies)
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity · Phase 3 · Amgen
- A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists · Phase 3 · Colorado Prevention Center
Vaccines (2 active studies)
- Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test · Aptitude Medical Systems
- A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations · Phase 4 · ModernaTX, Inc.
Pediatric (2 active studies)
- Studying Phenotypic Risks for Obesity and Underlying Traits in Young Infants · Pennington Biomedical Research Center
- Measurement of Energy Metabolism in Infants · Pennington Biomedical Research Center
Common conditions studied in Baton Rouge
- Obesity (13 active studies)
- Acute Myeloid Leukemia (6 active studies)
- Chronic Lymphocytic Leukemia (5 active studies)
- Heart Failure (4 active studies)
- Neoplasm Metastasis (4 active studies)
- Overweight (4 active studies)
Leading research sponsors in Baton Rouge
- Pennington Biomedical Research Center
- National Cancer Institute (NCI)
- AstraZeneca
- NRG Oncology
- Sanofi
Frequently asked questions
How many paid clinical trials are currently recruiting in Baton Rouge?
There are approximately 191 recruiting clinical trials in Baton Rouge, Louisiana listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Baton Rouge pay participants?
Most recruiting trials in Baton Rouge compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Baton Rouge?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Baton Rouge?
The most common conditions under active study in Baton Rouge include Obesity (13), Acute Myeloid Leukemia (6), Chronic Lymphocytic Leukemia (5), Heart Failure (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Baton Rouge?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Baton Rouge on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Baton Rouge?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Baton Rouge?
Recruiting research sites in Baton Rouge include Pennington Biomedical Research Center, Mary Bird Perkins Cancer Center, Our Lady of the Lake Physician Group, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Baton Rouge right now?
The largest active categories in Baton Rouge are Cancer & tumors (74), Diabetes & metabolic (25), Neurology & pain (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.